The Italian experience of the national registry of renal biopsies  by Gesualdo, Loreto et al.
Kidney International, Vol. 66 (2004), pp. 890–894
The Italian experience of the national registry of renal biopsies
LORETO GESUALDO, ANNA MARIA DI PALMA, LUIGI FRANCESCO MORRONE,
GIOVANNI FABRIZIO STRIPPOLI, and FRANCESCO PAOLO SCHENA, ON BEHALF OF THE ITALIAN
IMMUNOPATHOLOGY GROUP, ITALIAN SOCIETY OF NEPHROLOGY
Dipartimento di Scienze Biomediche, Sezione di Nefrologia, Universita’ di Foggia, Italy; Dipartimento dell’Emergenza e dei
Trapianti di Organi (DETO), Sezione di Nefrologia, Universita’ di Bari, Italy
The Italian experience of the national registry of renal biopsies.
Background. Although several registries collecting data of
patients with kidney diseases exist, there are only a few reg-
istries which specifically collect data relating to renal biopsy; one
such registry is the Italian Registry of Renal Biopsies (IRRB).
The aim of this study was to report on the relative frequency
of nephropathies according to gender, age at time of biopsy,
clinical presentation and renal function, based on the histologic
diagnosis during the years 1996 to 2000.
Methods. We evaluated data relating to 14607 renal biop-
sies, provided by 128 renal units in Italy. Data entry was per-
formed by using the Internet-based database directly (URL
http://www.irrb.net). Clinical presentation was defined as uri-
nary abnormalities (UA), nephrotic syndrome (NS), acute
nephritic syndrome (ANS). Renal diseases were divided in four
major categories: (1) primary glomerulonephritides (GN); (2)
secondary GN; (3) tubulointerstitial nephropathies (TIN); and
(4) vascular nephropathies (VN).
Results. Primary GN, TIN, and VN were more frequent in
males compared to females while secondary GN was more
frequent in females. Diseases whose frequency was higher in
males were IgA nephropathy (IgAN), benign nephroangioscle-
rosis (BNA), and acute tubular necrosis (ATN). A significantly
higher frequency of immune-mediated secondary GN, as well
as primary GN, including minimal change disease (MCD), focal
segmental glomerulosclerosis (FSGS), and mesangiocapillary
GN (MCGN), was shown in females. Primary and secondary
GN, TIN, and VN were more frequent in the range 15 to 65 years
of age. At the time of biopsy 77% of primary GN and 61% of sec-
ondary GN presented with normal renal function. Acute renal
failure (ACR) was more present in TIN (52%), while chronic
renal failure (CRF) was more frequent in VN (47%).
Conclusion. We believe collection of data relating to renal
biopsies in a national registry is a useful tool for nephrologists
in that it meets one of the current challenges facing the clinical
research enterprise. The availability of these data will allow
epidemiologic studies in health care to answer the several open
questions in both prevention and treatment of renal diseases.
One of the key features for the development of good
quality clinical epidemiologic research has been identi-
fied in the development of adequate flexible databases
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for the collection of epidemiologic data relating to spe-
cific diseases [1]. Although several registries collecting
data of patients with kidney diseases exist [2–7], there
are only a few registries which specifically collect data re-
lating to renal biopsy; one such registry is the Italian Reg-
istry of Renal Biopsies (IRRB) [8–11]. In 1987, the Renal
Immunopathology Study Group of the Italian Society of
Nephrology started this registry. During the years 1987
and 1988 data of renal biopsies were collected by spe-
cific questionnaires filled out by the participating centers.
Only limited information was collected, mainly data of
the histologic diagnosis. Since 1989 and up to 1995, addi-
tional information were collected, including age, gender,
clinical presentation, and renal function at the time of
renal biopsy [8–11]. In 1996, a more complete version
of the paperwork was generated and translated into a
user-friendly relational database. Information collected
in the database included a variety of indicators, such
as serum creatinine, daily proteinuria, blood pressure,
height and body weight, viral markers, clinical presen-
tation, hemoglobin values, and current medications [12].
At present, all the information collected in the database
is also accessible via the Internet. This system allows shar-
ing of materials among the involved participating centres.
Data available in the IRRB are being used for epidemi-
ologic studies both at a local and national level.
The aim of this study was to report on the relative fre-
quency of nephropathies according to gender, age, clinical
presentation and renal function, based on the histologic
diagnosis.
METHODS
We evaluated data relating to 14,607 renal biopsies col-
lected in the IRRB during the years 1996 to 2000. These
data were provided by 128 renal units in Italy. Data entry
was performed by using the Internet-based database di-
rectly (URL http://www.irrb.net). Each participating cen-
ter was assigned a user ID and password to access the
site for consultation and data entry. We considered gen-
der, age at time of biopsy, clinical presentation [defined
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Fig. 1. Frequency of histologic diagnosis on the basis of clinical presentation of nephropathy. Abbreviations are: IgAN, IgA nephropathy; MGN,
membranous GN; FSGS, focal segmental glomerulosclerosis; non IgAN, mesangioproliferative GN without IgA deposits; MCD, minimal change
disease; MCGN, mesangiocapillary GN; MEDAGN, metabolic and hereditary disorder–associated GN; DAGN, dysgammaglobulinemia-associated
GN; IDAGN, infectious disease–associated GN; LDAGN, liver disease–associated GN; MAGN, malignancy-associated GN; CTIN, chronic tubuloin-
terstitial nephropathy; ATIN, acute tubulointerstitial nephropathy; ATN, acute tubular necrosis; MM-associated TIN, multiple myeloma-associated
tubulointerstitial nephropathy; BNA, benign nephroangiosclerosis; TM, thrombotic microangiopathy; MNA, malignant nephroangiosclerosis; CN,
cortical necrosis; EPH, preeclampsia; NS, nephrotic syndrome; ANS, acute nephritic syndrome; UA, urinary abnormality.
as urinary abnormalities (UA), nephrotic syndrome (NS),
acute nephritic syndrome (ANS)], and renal function.
Renal diseases were divided in four major categories:
(1) primary glomerulonephritides (GN); (2) secondary
GN; (3) tubulointerstitial nephropathies (TIN); and (4)
vascular nephropathies (VN).
Mesangial glomerulonephritis (both IgA and non IgA
mesangial nephropathy), membranous GN (MGN), focal
segmental glomerulosclerosis (FSGS), minimal change
disease (MCD), mesangiocapillary GN (MCGN), cres-
centic GN and poststreptococcal GN were considered
as primary GN. Immune-mediated GN (systemic lupus
erythematosus, Scho¨nlein-Henoch purpura, amyloido-
sis, Goodpasture’s syndrome, necrotizing vasculitis,
connective disease, and sarcoidosis), metabolic and
hereditary-disorder-associated GN (MEDAGN) (dia-
betes mellitus, Alport’s syndrome, Fabry disease, nail-
patella syndrome, congenital NS, and other heredi-
tary disorders), dysgammaglobulinemia-associated GN
(DAGN) (essential mixed cryoglobulinemia, Walden-
strom’s macroglobulinemia, monoclonal gammopathy,
and light-chain disease), infectious disease–associated
GN (IDAGN) (nonstreptococcal GN, endocarditis, ven-
triculoatrial shunt nephritis, and others), liver disease–
associated GN (LDAGN), and malignancy-associated
GN (MAGN) were considered as secondary GN. Chronic
TIN (CTIN), acute TIN (ATIN), acute tubular necro-
sis (ATN), and multiple myeloma-associated TIN were
considered among TIN. Benign nephroangiosclerosis
(BNA), thrombotic microangiopathy (TM), malignant
nephroangiosclerosis (MNA), cortical necrosis (CN), and
preeclampsia (EPH) were considered among VN.
Data of 905 renal biopsies which could not be ad-
equately classified due to inadequate data entry or
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Table 1. Italian Immunopathology Group, SIN
City Hospital Chief Referring
Aosta Regionale Alloatti Gaiter
Torino G. Bosco Quarello Rollino-
Beltrame
Torino Molinette Piccoli Stratta
Torino CMID Roccatello Alpa
Torino Reg. Margherita Coppo Porcellini
Alessandria Ospitalieri Iberti Demicheli
Biella Degli Infermi Bajardi Caramello
Novara Della Carita` Verzetti Chiarinotti
Borgomanero SS. Trinita` Cavagnino Airoldi
Cuneo S. Croce Ghezzi Canepari
Ivrea Civile Giacchino Aimino
Milano S. Raffaele Bianchi Slaviero
Milano Maggiore Ponticelli Banfi
Milano Niguarda Civati Confalonieri
Milano S. C. Borromeo Colasanti Ferrario
Milano Sacco Barbiano Genderini
Milano S. Paolo Brancaccio Volpi
Milano Fatebenefratelli Sorgato Castiglione
Milano De Marchi Edefonti Giani
Lodi Maggiore Imbasciati Farina
Melegnano Predabissi Grassi Lupi
Cin. Balsamo Bassini Buccianti Saruggia
Legnano Civile Guastoni Levati
Magenta G. Fornaroli Novi Baroli
Monza S. Gerardo Redaelli Malnati
Vimercate Osp. di Vimercate Sessa Righetti
Treviglio Consorziale Borghi Moriggi
Brescia P.O. di Montichiari Brandi Bassi
Brescia Spedali Civili Maiorca Strada
Como S. Anna Grillo Grillo
Lecco A. Manzoni Locatelli Pozzi
Busto Arsizio Civile Giangrande D’Amato
Cremona Ist. Ospitalieri Malberti Bufano
Sondrio Civile Pedrini De Cristofaro
Mantova Carlo Poma Tarchini Baraldi
Pavia Clinica del Lavoro Salvadeo Segagni
Pavia Pol. S. Matteo Dal Canton Esposito
Genova DIMI Deferrari Garibotto
Genova S. Martino Cannella Mulas
Genova Gaslini Perfumo Barbano
Imperia Civile Cavatorta Re
Trento S. Chiara Rovati Comotti
Udine S. Maria Mioni Boscutti
Misericordia
Udine Universita` Romano
Trieste Osp. Di Cattinara Panzetta Savoldi
Trieste Garofalo Pennesi
Dolo Civile Meneghel
Chioggia Civile Munaretto Urso
Feltre Civile Nachtigal Antonucci
Pordenone S. Maria degli Tesio Raimondi
Angeli
Treviso Civile Calconi Dugo
Castelfranco S. Giacomo Cascone De Fino
Veneto
Padova Univ. Pediatria Zacchello Murer
Camposampiero P. Cosma Bonadonna
Verona Civile Maggiore Maschio Lupo
Bologna Malpighi Zucchelli Pasquali
Bologna S. Orsola Stefoni Frasca`
Rimini Degli Infermi Cagnoli Rigotti
Parma Riuniti-Nefrologia Cambi Allegri
Ravenna S. Maria delle Croci Fusaroli Fabbri
Reggio Emilia S. Maria Nuova Borgatti Rustichelli
Ferrara S. Anna Gilli Stabellini
Modena Policlinico Albertazzi Furci
Table 1. continued.
City Hospital Chief Referring
Firenze Careggi Salvadori Bergesio
Firenze Meyer Bartolozzi Lavoratti
Prato Civile Amato Aterini
Bagno a S. Maria Annunziata Maggiore Nigrelli
Ripoli
Arezzo S. Maria Sasdelli Bizzarri
Pisa Dip. Di Med. Interna Bianchi Panichi
Pisa S. Chiara Rindi Pasquariello-
Basini
Ancona Umberto I Mioli Fanciulli
Roma Pol. Umberto I Cinotti Pecci
Roma Fatebenefratelli Chiappini Selvaggi
Roma Tor Vergata Splendiani Costanzi
Roma S. Giovanni Balducci Gamberini
Roma S. Camillo Forlanini Di Giulio De Paolis
Roma Lazzaro Spallanzani Cherubini
Roma Sant’Eugenio Casciani Meloni
Roma Sandro Pertini Paone Galliani
Roma Bambin Gesu` Rizzoni
Ostia G.B Grassi Friggi Fortunato
Viterbo Degli Infermi Ancarani Feriozzi
Formia P.O. Formia Moscoloni Treglia
Perugia Silvestrini Buoncristiani Brugnano
Pescara Santo Spirito Ciofani D’Andrea
Chieti Pol. San Camillo Bonomini Amoroso
Napoli University Federico II Andreucci Balletta
Napoli II Universita`-Nefrologia De Santo Pollastro
Napoli Pellegrini Sorice Nuzzi
Napoli Santobono Pecoraro Pota-Fella
Avellino S. Giuseppe Moscati De Simone Iannaccone
Salerno S. Giovanni di Dio Cioffi Ricci
Polla L. Curio Pagano Gigliotti
Bari Policlinico Schena Manno
Bari Santa Rita La Raia
Bari Policlinico- Pediatria Penza Aceto-
Francioso
Bari Giovanni XXIII Caringella Messina-
Puteo
Acquaviva Miulli Chiarulli Cazzato-
Casucci
Altamura Civile Petrarulo Pallotta
Monopoli San Giacomo Pastore Grasso
Putignano Santa Maria degli Angeli Giannattasio Gernone
Foggia Ospedali Riuniti Procaccini
S. G. Sollievo Sofferenza Stallone D’Errico
Rotondo
San Severo Teresa Maselli Avanzi Casale
Taranto SS. Annunziata Di Maggio
Manduria M. Giannuzzi Chimienti Distratis
Martina Osp. Gioia Basile Montanaro
Franca
Lecce Vito Fazzi Mastrangelo Patruno
Scorrano I. Veris delli Ponti Tasco Stefanelli
Galatina Santa Caterina Novella Gigante Gallucci
Matera Osp. Riuniti Lopez Santarsia
Reggio Melacrino Zoccali Martorano
Calabria
Cosenza Annunziata Bonofiglio De Napoli
Catanzaro Policlinico-Nefrologia Fuiano Marino
Palermo Civico Visconti
Palermo Catt. Di Med Interna Cerasola Li Vecchi
Palermo G. Cristina Maringhini Sapia
Palermo Sez. Tecn. Emodialitica Galione
Catania Vittorio Emanuele Spata Spanti
Catania Universita` Fatuzzo Rapisarda
Catania San Luigi Liuzzo Figura
Catania Cannizzaro Di Landro Seminara
Messina Catt. Medicina Int. Buemi Pettinato
Messina Regina Margherita Giorgianni Gattarello
Messina Policlinico-Nefrologia Bellinghieri Santoro
Siracusa Umberto I Daidone Pagano
Cagliari Brotzu Altieri Pani
Sassari Ist. Patologia Medica Satta Cigni
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biopsies which were nondiagnostic (inadequate sampling
of materials, normal renal tissue) or diagnoses of end-
stage kidney diseases, were not included in the present
analysis.
Data are reported as prevalence and were coded in
contingency tables and compared by v 2 test.
RESULTS
We considered 14,607 renal biopsies, of which 89.9%
were from native and 10.1% were from transplant kid-
neys. Of all diseases of native kidney, primary GN were
the most frequent (64.3%), followed by secondary GN
(24.7%), TIN (5.3%) and VN (4.7%).
Primary GN were more frequent in males (64%) com-
pared to females (36%); similarly true for TIN (males
57% and females 43%) and VN (males 70% and females
30%). On the contrary, secondary GN were more fre-
quent in females (males 45% and females 55%). Dis-
eases whose frequency was higher in males were IgA
nepropathy (IgAN) (males 39.3% and females 27.8%;
P < 0.0001), BNA (males 75.8% and females 56.1%;
P < 0.0001), and ATN (males 18.8% and females 11.1%,
P < 0.01). A significantly higher frequency of immune-
mediated secondary GN (males 55.9% and females
72.5%; P < 0.0001) as well as primary GN, including
MCD (males 7.4% and females 10.3%; P < 0.0001),
FSGS (males 12.3% and females 14.7%; P < 0.005),
and MCGN (males 6.2% and females 8.0%; P < 0.005)
was shown in females.
In terms of age at the time of renal biopsy, primary
and secondary GN, TIN, and VN were most frequent in
the range 15 to 65 years of age. Below the age of 15 the
most frequent primary GN was MCD (<15 years 23.3%,
15 to 65 years 7.3%, and >65 years 7.5%; P < 0.0001),
and the most frequent secondary GN were MEDAGN
(<15 years 30.4%, 15 to 65 years 20.0%, and >65 years
16.3%; P < 0.0001). The most frequent TIN were CTIN
(<15 years 60.6%, 15 to 65 years 48.2%, and >65 years
30.0%; P < 0.0001), and the most frequent VN was TM
(<15 years 63.6%, 15 to 65 years 17.4%, and >65 years
13.8%; P < 0.0001). On the contrary, above the age of
65 the most frequently biopsied nephropathies for VN
were BNA (<15 years 18.2%, 15 to 65 years 67.4%, and
>65 years 80.7%; P < 0.0001), the most frequent among
primary and secondary GN was MGN (<15 years 3.5%,
15 to 65 years 18.0%, and >65 years 45.2%; P < 0.0001),
and the most frequent among TIN was MM-associated
TIN (<15 years 0.0%, 15 to 65 years 9.8%, and >65 years
25.8%; P < 0.0001).
Figure 1 indicates the clinical presentation of histo-
logically ascertained nephropathies. The main reasons
for performing a renal biopsy were UA (51% of cases
of primary GN, 48% of cases of secondary GN, 70%
of cases of TIN, and 80% of cases of VN). The type of
nephropathies which most frequently presented with NS
were MGN (44.1%), FSGS (16.9%), and MCD (16.7%)
among primary GN, MM-associated TIN (36.4%) among
TIN, and DAGN (30.4%) among secondary GN. The
diseases which most frequently presented with ANS
among primary GN were crescentic GN (21.6%), MCGN
(11.3%), and poststreptococcal GN (16.2%). Among sec-
ondary GN the ones most frequently presenting with
ANS were immune-mediated GN (80.9%) and IDAGN
(16.9%); among TIN, these were ATIN (58.3%), and
among VN these were TM (50.0%). Nephropathies which
were most frequently associated with UA were BNA
(86.6%) among NV, CTIN (62.7%) among TIN, and
IgAN (59.7%) among primary GN.
Finally, at the time of biopsy 77% of primary GN and
61% of secondary GN presented with normal renal func-
tion. Acute renal failure was mainly present in TIN (52%)
while chronic renal failure was mainly present in VN
(47%).
DISCUSSION
We confirm previously published data that renal dis-
eases are more frequent in men, with the exception of
secondary GN [10, 11, 14]. The higher relative frequency
of secondary GN in females may be explained by the
immune-mediated nature of these forms of GNs asso-
ciated with systemic lupus erythematosus which occurs
more frequently in this gender. We found that all cate-
gories of renal diseases occur mainly between the ages of
15 and 65; this may well be explained by the tendency not
to perform biopsies in elderly patients and the practice
of performing renal biopsies in children only when the
disease is persistent in time and presenting with major
relevant symptoms. In our data, FSGS and MCD, which
typically affect children, were not very represented com-
pared to MGN, which, as is known, is typical of adult
age. Finally, the diagnosis of primary and secondary GN
is generally done in the absence of renal function ab-
normalities; this indicates the current tendency of both
doctors and patients not to undervalue syndromes asso-
ciated with renal diseases and urinary abnormalities in
particular.
CONCLUSION
We believe collection of data relating to renal biopsies
in a national registry is a useful tool for nephrologists
in that it meets one of the current challenges facing the
clinical research enterprise [1]. The availability of these
data will allow epidemiologic studies in health care to
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answer the several open questions in both prevention and
treatment of renal diseases.
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